Back to results
US 2021/0275672 A1Published application
Compound usable as cationic lipid
AssigneeKyowa Hakko Kirin Co., Ltd.
InventorsShintaro HOSOE, Hayato YABUUCHI
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound represented by formula (I) usable as a cationic lipid that facilitates introduction of a nucleic acid, for example, into a cell, and a composition or the like containing the compound.
Claims18
A compound represented by formula (I), or a pharmaceutically acceptable salt thereof:
- wherein R1 and R2 are, the same or different, a hydrogen atom or C1-C3 alkyl;
- A1 and A2 are, the same or different, linear or branched C8-C20 alkylene or C8-C20 alkenylene;
- M1 and M2 are, the same or different, selected from the group consisting of —C═C—, —OC(O)—, —C(O)O—, —SC(O)—, —C(O)S—, —OC(S)—, —C(S)O—, —SS—, —C(R5)═N—, —N═C(R5)—, —C(R5)═N—O—, —O—N═C(R5)—, —N(RS)C(O)—, —C(O)N(RS)—, —N(RS)C(S)—, —C(S)N(RS)—, —N(R5)C(O)N(R6)—, —N(RS)C(O)O—, —OC(O)N(R5)—, and —OC(O)O—;
- R5 and R6 are, the same or different, a hydrogen atom or C1-C3 alkyl;
- and
- B1 and B2 are, the same or different, linear or branched C1-C16 alkyl or C2-C16 alkenyl.
3 more elements
(canceled)
Dependencies are inferred from the claim text.